New Exploration of Early Catheter Removal: The Application of the ERAS Concept in Male Comatose Patients in Neurosurgery
Keywords:
Enhanced recovery after surgery, Early catheter removal, Neurosurgery, comatose, urinary tract infectionsAbstract
Objective: Neurosurgical male comatous patients need urine catheters. Long-term indwelling can impede recovery with urinary tract infections and retention. Enhanced Recovery After Surgery (ERAS) has shown potential in several domains, expanding urinary catheter management alternatives. This study investigates ERAS applicability. Methods: This study included 92 male neurosurgical coma patients who received indwelling urinary catheters, they were split into the study group (46 cases, receiving ERAS treatment) and the control group (46 cases, receiving conventional care) according to random number method. The two groups' age, Body Mass Index (BMI) index, medical history, smoking/drinking history, and primary disease type were compared. The two groups' urinary tract infection, urine retention, early extubation, first urination, and indwelling catheter time were documented during the trial. Results: The study group outperformed the control group in all areas. In the study group, urinary tract infections were 2.17% and urine retention was 6.52%, considerably lower than 17.39% and 23.91% in the control group (p < 0.05). Early extubation rate was 84.78%, higher than 65.22% in the control group (p < 0.05). First urination time was 107.26 ± 13.87 hours, and indwelling catheter time was 13.00 (12.00, 14.00) days, significantly shorter than the control group (144.37 ± 12.26) hours and 22.00 (21.00, 23.00) days, respectively) (p < 0.001). Conclusion: The ERAS concept for early catheter removal in male comatous neurosurgery patients can reduce complications, increase the rate of early catheter removal, and shorten the first urination and indwelling catheter time, which is important for patient rehabilitation.
Published
Issue
Section
License
Copyright (c) 2025 The Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License.